Skip to main content
. 2023 Jan;103(1):21–37. doi: 10.1124/molpharm.122.000614

TABLE 1.

Tolerant and intolerant residues from RGS domains of interest that also overlap with highly deleterious somatic mutations were selected for assessment of their impact on RGS functions. Amino acids reported in the COSMIC cancer database were selected based on the criteria that were predicted to be pathogenic by the FATHMM score to be highly pathogenic. Scores above 0.5 are deleterious; scores ≥0.7 are classified as pathogenic.

Pathogenic Score Cancer Type 3DMTR (Score)
RGS14
 S127P 0.91 Stomach Carcinoma Tolerant (1.03)
 D137Y 0.97 Prostate Carcinoma Tolerant (0.93)
 R173C 0.81 Large Intestine Carcinoma Intolerant (0.50)
 R173H 0.97 Large Intestine Carcinoma Intolerant (0.50)
RGS10
 S64T 0.96 Lung Carcinoma Tolerant (0.91)
 K89M 0.84 Thyroid Carcinoma Intolerant (0.48)
RGS4
 K125Q 0.97 Lung Adenocarcinoma Intolerant (0.48)
 E126K 1.00 Skin Melanoma Intolerant (0.42)
 E135K 1.00 Skin Carcinoma, Melanoma, Upper Aerodigestive Tract Carcinoma Tolerant (1.14)